USP28 and B-cell chronic lymphocytic leukemia: Here we present evidence that USP28-mediated dysregulation of NOTCH1 activity is another cause of activation of NOTCH1 signaling in CLL and propose that targeting USP28 might be of benefit in CLL patients with active NOTCH1 signaling.